Palle Jeppesen, M.D. – FDA Inspection, May 31, 2024

Record Details

This FDA Inspection record concerns Palle Jeppesen, M.D., with an inspection on May 31, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Palle Jeppesen, M.D.
Inspection Date: May 31, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Dina A. Tallman (Company Rep)

View Company Profile

ID · 16fa0e54-6232-4d70-ae6d-2e0d827dd7e4

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1242849
FDA center: Human Drugs
Project area: Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Palle Jeppesen, M.D.

FDA Inspection

Palle Jeppesen, M.D.May 31, 2024